AtriCure reported a decrease in worldwide revenue by 3.3% year-over-year, with U.S. revenue decreasing by 3.1% and international revenue decreasing by 4.1%. The company's gross profit was $40.3 million, and the loss from operations was $4.0 million. Net loss per share was $0.11, while adjusted EBITDA was a positive $4.2 million.
Worldwide revenue decreased by 3.3% year over year to $54.8 million.
U.S. revenue decreased by 3.1% year over year to $44.7 million.
International revenue decreased by 4.1% year over year to $10.1 million.
Adjusted EBITDA was a positive $4.2 million compared to a loss of $2.2 million for the third quarter of 2019.
Management expects revenue to be $56 million to $60 million for the fourth quarter of 2020 and $205 million to $209 million for the full year 2020. Full year adjusted EBITDA loss is expected to be approximately $10 million.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance